Stifel analyst Dae Gon Ha downgrades Applied Genetic Techs (NASDAQ:AGTC) from Buy to Hold and lowers the price target from $3 to $0.34.
Keybanc Maintains Overweight on F5, Lowers Price Target to $182
Keybanc analyst Thomas Blakey maintains F5 (NASDAQ:FFIV) with a Overweight and lowers the price target from $190 to $182.